We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+11.24%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$55.2B
AUM Growth
+$1.23B
Cap. Flow
-$3.83B
Cap. Flow %
-6.94%
Top 10 Hldgs %
17.05%
Holding
2,357
New
126
Increased
872
Reduced
1,099
Closed
169

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$154M
2
COP icon
ConocoPhillips
COP
+$127M
3
CVX icon
Chevron
CVX
+$111M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$107M
5
NRG icon
NRG Energy
NRG
+$83.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$376M
2
META icon
Meta Platforms (Facebook)
META
+$195M
3
TGT icon
Target
TGT
+$191M
4
ELV icon
Elevance Health
ELV
+$139M
5
AMZN icon
Amazon
AMZN
+$109M

Sector Composition

Rank Sector Weight
1 Technology 24.19%
2 Healthcare 15.68%
3 Industrials 12.36%
4 Financials 11.55%
5 Consumer Discretionary 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHR icon
2251
Phreesia
PHR
$769M
-14,284
Closed -$881K
PPBI
2252
DELISTED
Pacific Premier Bancorp
PPBI
-8,671
Closed -$359K
PSNL icon
2253
Personalis
PSNL
$1.55B
-10,277
Closed -$198K
PTON icon
2254
Peloton Interactive
PTON
$2.41B
-11,939
Closed -$1.01M
RAPT
2255
DELISTED
RAPT Therapeutics
RAPT
-1,783
Closed -$443K
RBC icon
2256
RBC Bearings
RBC
$17.6B
-1,693
Closed -$359K
RCUS icon
2257
Arcus Biosciences
RCUS
$3.66B
-5,869
Closed -$205K
RFL icon
2258
Rafael Holdings
RFL
$103M
-6,810
Closed -$206K
RYTM icon
2259
Rhythm Pharmaceuticals
RYTM
$7.95B
-10,191
Closed -$133K
SCOR icon
2260
Comscore
SCOR
$110M
-3,599
Closed -$281K
SGC icon
2261
Superior Group of Companies
SGC
$205M
-18,403
Closed -$429K
SMSI icon
2262
Smith Micro Software
SMSI
$16.2M
-2,521
Closed -$488K
SPCE icon
2263
Virgin Galactic
SPCE
$415M
-1,000
Closed -$506K
SPR
2264
DELISTED
Spirit AeroSystems
SPR
-16,362
Closed -$723K
SRRK icon
2265
Scholar Rock
SRRK
$6.32B
-8,519
Closed -$281K
STRO icon
2266
Sutro Biopharma
STRO
$423M
-1,452
Closed -$274K
SUPN icon
2267
Supernus Pharmaceuticals
SUPN
$2.74B
-8,887
Closed -$237K
SWTX
2268
DELISTED
SpringWorks Therapeutics
SWTX
-7,258
Closed -$460K
TAL icon
2269
TAL Education Group
TAL
$6.94B
-34,233
Closed -$166K
TPB icon
2270
Turning Point Brands
TPB
$1.79B
-7,260
Closed -$347K
TR icon
2271
Tootsie Roll Industries
TR
$2.97B
-11,318
Closed -$297K
TRS icon
2272
TriMas Corp
TRS
$1.43B
-38,558
Closed -$1.25M
TSE
2273
DELISTED
Trinseo
TSE
-27,031
Closed -$1.46M
VIR icon
2274
Vir Biotechnology
VIR
$1.5B
-9,498
Closed -$413K
VRT icon
2275
Vertiv
VRT
$104B
-34,365
Closed -$828K

Similar funds

AQR Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, AQR Capital Management held 2,357 positions worth $55.2B, up 2.3% from $53.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

AQR Capital Management withdrew a net $3.83B in Q4 2021, closing 169 positions and reducing 1,099 holdings. Its most notable exit was Kansas City Southern, an estimated $7.54M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AQR Capital Management opened a new position in Live Nation Entertainment worth $8.76M.

  • AQR Capital Management's largest Q4 2021 buy was Live Nation Entertainment: 73,147 shares worth $8.76M.
  • AQR Capital Management added most to Tesla in Q4 2021, an estimated $154M increase.
  • AQR Capital Management's biggest Q4 2021 reduction was Apple, cutting an estimated $376M.
  • AQR Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $7.54M.
  • AQR Capital Management's ten largest holdings make up 17% of its $55.2B portfolio in Q4 2021.
  • AQR Capital Management opened 126 new positions and closed 169 in Q4 2021.
  • AQR Capital Management's portfolio value rose 2.3% quarter-over-quarter to $55.2B.

Based on AQR Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.